Report Information More information from: https://www.marketresearchfuture.com/reports/925
Global Precision Medicine Market Research Report – Forecast to 2022 Report / Search Code: MRFR/HC/0420-CRR
Price
Description:
1-user PDF : $ 4450.0
Publish Date: March, 2017
Enterprise PDF : $ 6250.0
Global Precision Medicine market Information, By Ecosystem (pharma & biotech companies, diagnostic tool companies, healthcare IT/ big data companies, clinical laboratories), By Sub-markets (companion diagnostics, biomarker-based test, targeted therapeutics, pharmacogenomics, molecular diagnostics, others), By Therapeutics (cancer/oncology, cardiovascular disease, central nervous system, infectious diseases, others) - Forecast to 2022 Market Synopsis of Global Precision Medicine Market: Market Scenario: Precision medicine refers to medicines developed as per an individual’s genetic profile that helps as a guide for the prevention, diagnosis and treatment of diseases. The global precision medicine market was valued at $38.92 billion in 2015, and is expected to reach $88.64 billion by 2022. Thus the market is expected to perform a growth at a CAGR of 12.48% from 2015 to 2022. The major market driving factor for precision medicine are patient’s involvement in personal healthcare, integration of wireless technologies with portable healthcare devices, and increase in genetic diseases (due to mutation, UV rays) among others. The market constraints include potential threat to personal data, high diagnostic cost as a barrier, potential risk of hardware or software failure, stringent regulations and standards, lack of awareness about the possible applications of precision medicine, reimbursement policies and regulatory framework, limited knowledge about the application of test and techniques, lack of research and evidences creating hindrances in its application.
Study Objectives Global Precision Medicine Market:
To provide detailed analysis of the market structure along with forecast for the next 7 years of the various segments and subsegments of the global precision medicine market To provide insights about factors affecting the market growth To analyze the market based on various factors- price analysis, supply chain analysis, porters five force analysis etc. To provide historical and forecast revenue of the market segments and sub-segments with respect to four main geographies and their countries- Americas, Europe, AsiaPacific, and Middle East & Africa. To provide country level analysis of the market with respect to the current market size and future prospective To provide country level analysis of the market for segments by ecosystem (pharma & biotech companies, diagnostic tool companies, healthcare it/ big data companies, clinical laboratories), by submarkets (companion diagnostics, biomarkerbased test, targeted therapeutics, pharmacogenomics, molecular diagnostics, others), by therapeutics (cancer/oncology, cardiovascular disease, central nervous system, infectious diseases, others) To provide overview of key players and their strategic profiling in the market, comprehensively analyzing their core competencies, and drawing a competitive landscape for the market To track and analyze competitive developments such as joint ventures, strategic alliances, mergers and acquisitions, new product developments, and research and developments globally.
Global Precision Medicine Market, by Region 2015 & 2022 (USD million)
Intended Audience: Global Precision Medicine manufacturers Global Precision Medicine suppliers Research and Development Laboratories Market Research and Consulting Service Providers
Key Finding: The global precision medicine market is expected to reach USD 88.64 billion by 2022. By ecosystem diagnostic tool companies holds the largest market share of precision medicine market and is expected to reach USD 27.56 billion by 2022. By sub-market, company diagnostics holds the largest market share of precision medicine market and is expected to reach USD 21.32 billion by 2022.
Key Players for Global Precision Medicine Market: Abbott Laboratories, Almac Group, Ltd., Asuragen, Inc., BiomĂŠrieux Sa, Cepheid Inc., Cetics Healthcare Technologies Gmbh, Ge Healthcare, Glaxosmithkline Plc, Johnson & Johnson, Laboratory Corporation Of America
Holdings, Medtronic, Novartis, Pfizer Inc., Qiagen, Biobase Gmbh, Quest Diagnostics Inc, Randox Laboratories Ltd., Sanofi Pharma, Takeda Pharmaceutical Company Limited, Teva Pharmaceutical Industries Ltd., AbBiotics Sa, Caris Life Sciences, Healthcore, Inc., Ibm, Innventis, Intel Corporation, Molecular Health Gmbh, Precision For Medicine
Segments: Global Precision Medicine market has been segmented on the basis of ecosystem, sub-market, therapeutics and region. Regional Analysis of Global Precision Medicine Market: Globally North America is the largest market for global precision medicine. Europe is the second-largest market for global precision medicine. The near future market for precision medicine will be dominated by the developed regions with developing regions providing a supporting role only. However the developing regions market particularly Asia Pacific will be the fastest growing and is likely to be the key to the future. The report for Global Precision Medicine Market of Market Research Future comprises extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives the clear picture of current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions. Contents:
1 Report Scope 1.1 Scope Of The Study 1.2 Precision Medicine: Report Coverage 1.3 Research Methodology 1.3.1 Research Methodology For The Global Market Study 1.3.1.1 Geographical Analysis 1.3.1.2 Demand Side & Supply Side Analysis 1.3.1.3 Data Synthesis And Bridging 1.3.2 Global Precision Medicine: Research Methodology 1.3.3 Key Data Point Sources 1.3.3.1 Data Points Taken From Secondary Sources 1.3.3.2 Data Points Taken From Primary Sources 1.4 Report Description
2 Executive Summary 3 Market Overview 3.1 Introduction 3.2 Market Timeline 3.3 Key Participants, Strategies & Developments 3.3.1 Government Agencies 3.3.2 Academic Institutions 3.3.3 Device & Service Providers 3.4 Key Market Strategies And Developments 3.4.1 Introduction 3.4.2 Partnerships, Agreements, And Collaborations 3.4.3 Mergers & Acquisitions 3.4.4 Product Development And Launch 3.4.5 Business Expansion/Contracts 3.4.6 Patents, Approvals And Certifications 3.4.7 Others (Events & Recognitions) 4 Market Dynamics 4.1 Introduction 4.2 Market Drivers 4.2.1 Patients Involvement In Personal Healthcare 4.2.2 Technologies Driving The Market (E.G. Next-Generation Sequencing Technologies, Ultra-High Throughput Sequencing) 4.2.3 Increase In Genetic Diseases 4.2.4 Potential For More Targeted Therapies 4.2.5 Integration Of Big Data Healthcare Companies With Pharma & Biotech Companies 4.3 Market Challenges 4.3.1 Potential Threat To Personal Data 4.3.2 High Diagnostic Cost As A Barrier 4.3.3 Potential Risk Of Hardware Or Software Failure 4.3.4 Stringent Regulations And Standards 4.3.5 Lack Of Awareness About The Possible Applications Of Precision Medicine
4.3.6 Reimbursement Policies And Regulatory Framework 4.3.7 Limited Knowledge About The Application Of Test And Techniques 4.3.8 Lack Of Research And Evidences Creating Hindrances In Its Application 4.4 Market Opportunities 4.4.1 Introduction Of Precision Medicine Solutions In Developing Economies 4.4.2 Downsizing The Cost Of Genome Sequencing To Three Digits 5 Industry Dynamics 5.1 Value Chain Analysis 5.1.1 Device Manufacturer & Drug Producers 5.1.2 Healthcare Providers 5.1.3 Healthcare Its Or Big Data Companies 5.1.4 Regulators 5.1.5 Third Party Payers 5.1.6 Patients 5.2 Porter Five Force Analysis 5.2.1 Bargaining Power Of Buyer (Patient) 5.2.2 Bargaining Power Of Supplier 5.2.3 Threat From Substitute 5.2.4 Threat From A New Entrant 5.2.5 Intensity Of Competitive Rivalry 6 Consortiums, Certification, Regulations, And Standards 6.1 Introduction 6.1.1 Regulatory Bodies 6.1.1.1 Food And Drug Administration (Fda) 6.1.1.2 Medicines And Healthcare Products Regulatory Agency (Mhra) 6.1.1.3 Therapeutic Goods Administration (Tga)-Australia 6.1.1.4 ConformitĂŠ EuropĂŠenne (Ce) 6.1.2 Consortiums 6.1.3 Alliances/Associations 7 Global Precision Medicine Market By Ecosystem Players 7.1 Introduction 7.1.1 Market Statistics
7.2 Pharmaceuticals And Biotechnology Companies 7.2.1 Key Market Trends, Developments And Participants 7.2.1.1 Market Trends 7.2.1.2 Market Developments 7.2.1.3 Key Participants 7.3 Diagnostic Companies 7.3.1 Key Market Trends, Developments And Participants 7.3.1.1 Market Trends 7.3.1.2 Market Developments 7.3.1.3 Key Participants 7.4 Healthcare It Specialists/ Big Data Companies 7.4.1 Key Market Trends, Developments And Participants 7.4.1.1 Market Trends 7.4.1.2 Market Developments 7.4.1.3 Key Participants 7.5 Clinical Laboratories 7.5.1 Key Market Trends, Developments And Participants 7.5.1.1 Regulatory Bodies And Compliances 7.5.1.2 Market Trends 7.5.1.3 Key Participants 8 Global Precision Medicine Market By Sub-Markets 8.1 Introduction 8.1.1 Market Statistics 8.2 Companion Diagnostics 8.3 Biomarker-Based Test 8.3.1 Role Of Biobanking Into Biomarker 8.3.2 Key Participants 8.4 Targeted Therapeutics 8.4.1 Key Participants 8.5 Pharmacogenomics (Pgx) 8.5.1 Key Market Trends, Developments And Participants
8.5.1.1 Market Trends 8.5.1.2 Market Developments 8.5.1.3 Key Participants 8.6 Molecular Diagnostics 8.7 Others 8.7.1 Next-Generation Sequencing 8.7.2 Consumer Genomics 8.7.2.1 Key Participants 8.7.3 3d Printing 8.7.4 Prosthetics Market 8.7.5 Human Tissues Market 9 Global Precision Medicine Market By Therapeutics 9.1 Introduction 9.1.1 Market Statistics 9.2 Cancer/Oncology 9.2.1 Market Statistics 9.2.2 Types Of Cancer 9.2.3 Drugs & Tests 9.2.4 Key Market Trends, Developments & Participants 9.2.4.1 Market Trends 9.2.4.2 Market Developments 9.2.4.3 Key Participants 9.3 Cardiovascular Disease (Cvd) 9.3.1 Market Statistics 9.3.2 Drugs & Tests 9.3.3 Market Trends & Market Developments 9.3.3.1 Market Trend 9.3.3.2 Market Developments 9.3.3.3 Key Participants 9.4 Central Nervous System 9.4.1 Market Statistics 9.4.2 Neurological
9.4.2.1 Neurological Drugs & Tests 9.4.3 Psychiatric Disorders 9.4.3.1 Psychiatric Disorder Drugs & Tests 9.4.4 Market Tends & Market Developments 9.4.4.1 Market Trends 9.4.4.2 Key Developments 9.4.4.3 Key Participants 9.5 Infectious Diseases 9.5.1 Market Statistics 9.5.2 Infectious Diseases Drugs & Tests 9.5.3 Market Developments & Participants 9.5.3.1 Key Developments 9.5.3.2 Key Participants 9.6 Others 9.6.1 Market Statistics 9.6.2 Market Trends, Developments & Participants 9.6.2.1 Market Trends 9.6.2.2 Key Developments 9.6.2.3 Key Participants 10 Global Precision Medicine Market By Geography 10.1 Introduction 10.1.1 Market Statistics 10.2 The Americas 10.2.1 North America 10.2.1.1 The U.S. 10.2.1.2 Canada 10.2.1.3 Others 10.2.1.4 Key Market Trends, Developments And Participants 10.2.1.5 Regulations And Compliances 10.2.1.6 Market Trends 10.2.1.7 Market Developments
10.2.1.8 Key Participants 10.2.2 South America 10.2.2.1 Key Market Trends, Developments And Participants 10.2.2.2 Regulations And Compliances 10.2.2.3 Market Trends 10.2.2.4 Key Participants 10.3 Europe 10.3.1 Key Market Trends, Developments And Participants 10.3.1.1 Regulations And Compliances 10.3.1.2 Market Developments 10.3.1.3 Key Participants 10.4 Asia-Pacific (Apac) 10.4.1 Key Market Trends, Developments And Participants 10.4.1.1 Market Developments 10.4.1.2 Key Participants 10.5 Rest Of The World/Midde East & Africa (Mea) 10.5.1 Africa 10.5.1.1 Middle East 10.5.2 Key Market Developments And Participants 10.5.2.1 Market Developments 10.5.2.2 Key Participants 11 Company Profiles 11.1 Abbott Laboratories 11.1.1 Overview 11.1.2 Financials 11.1.2.1 Overall Financials 11.1.2.2 Financials By Segment 11.1.2.3 Financials By Region 11.1.2.4 Key Developments 11.1.3 Swot Analysis 11.2 Almac Group, Ltd. 11.2.1 Overview
11.2.2 Financials 11.2.3 Key Developments 11.2.4 Swot Analysis 11.3 Asuragen, Inc. 11.3.1 Overview 11.3.2 Financials 11.3.3 Key Developments 11.3.4 Swot Analysis 11.4 BiomĂŠrieux Sa 11.4.1 Overview 11.4.2 Financials 11.4.2.1 Overall Financials 11.4.2.2 Financials By Region 11.4.2.3 Financials By Segment 11.4.3 Key Developments 11.4.4 Swot Analysis 11.5 Cepheid Inc. 11.5.1 Overview 11.5.2 Financials 11.5.2.1 Overall Financials 11.5.2.2 Net Revenue By Segment 11.5.2.3 Net Revenue By Region 11.5.3 Key Developments 11.5.4 Swot Analysis 11.6 Cetics Healthcare Technologies Gmbh 11.6.1 Overview 11.6.2 Financials 11.6.3 Key Developments 11.6.4 Swot Analysis 11.7 Ge Healthcare 11.7.1 Overview
11.7.2 Financials 11.7.2.1 Overall Financials 11.7.2.2 Net Revenue By Segment 11.7.2.3 Financial Summary 11.7.3 Key Developments 11.8 Glaxosmithkline Plc (Gsk) 11.8.1 Overview 11.8.2 Financials 11.8.2.1 Overall Financials 11.8.2.2 Financials By Segment 11.8.2.3 Financials By Region 11.8.2.4 Financials By Therapeutics 11.9 Intomics A/S 11.9.1 Overview 11.9.2 Financials 11.9.3 Key Developments 11.9.4 Swot Analysis 11.10 Johnson & Johnson 11.10.1 Overview 11.10.2 Financials 11.10.2.1 Overall Financials 11.10.2.2 Net Revenue By Segment 11.10.2.3 Net Revenue By Region 11.10.3 Key Developments 11.11 Laboratory Corporation Of America Holdings 11.11.1 Overview 11.11.2 Financials 11.11.2.1 Overall Financials 11.11.2.2 Financials By Segment 11.11.3 Key Developments 11.11.4 Swot Analysis 11.12 Medtronic
11.12.1 Overview 11.12.2 Financials 11.12.2.1 Overall Financials 11.12.3 Key Developments 11.13 Novartis 11.13.1 Overview 11.13.2 Financials 11.13.2.1 Overall Financials 11.13.2.2 Financials By Region 11.13.2.3 Financials By Segment 11.14 Pfizer Inc. 11.14.1 Overview 11.14.2 Financials 11.14.2.1 Overall Financials 11.14.2.2 Net Revenue By Segment 11.14.2.3 Net Revenue By Region 11.14.3 Key Developments 11.14.4 Swot Analysis 11.15 Qiagen 11.15.1 Overview 11.16 Biobase Gmbh (Subsidiary) 11.16.1 Overview 11.16.2 Financials 11.16.2.1 Overall Financials 11.16.3 Key Developments (Biobase) 11.17 Quest Diagnostics Inc 11.17.1 Overview 11.17.2 Financials 11.17.2.1 Overall Financials 11.17.2.2 Net Revenue By Segment 11.17.3 Key Developments
11.17.4 Swot Analysis 11.18 Randox Laboratories Ltd. 11.18.1 Overview 11.18.2 Financials 11.18.3 Key Developments 11.18.4 Swot Analysis 11.19 Roche Holding Ag-Br 11.19.1 Overview 11.19.2 Financials 11.19.2.1 Overall Financials 11.19.2.2 Net Revenue By Segment 11.19.3 Key Developments 11.19.4 Swot Analysis 11.20 Sanofi Pharma 11.20.1 Overview 11.20.2 Financials 11.20.2.1 Overall Financials 11.20.2.2 Net Revenue By Segment 11.21 Takeda Pharmaceutical Company Limited 11.21.1 Overview 11.21.2 Financials 11.21.2.1 Overall Financials 11.21.3 Key Developments 11.21.4 Swot Analysis 11.22 Teva Pharmaceutical Industries Ltd. 11.22.1 Overview 11.22.2 Financials 11.22.2.1 Overall Financials 11.22.2.2 Net Revenue By Segment 11.22.2.3 Net Revenue By Segment 11.22.3 Key Developments 11.22.4 Swot Analysis
11.23 Ab-Biotics Sa 11.23.1 Overview 11.24 Caris Life Sciences 11.24.1 Overview 11.25 Healthcore, Inc. 11.25.1 Overview 11.26 Ibm 11.26.1 Overview 11.27 Innventis 11.27.1 Overview 11.28 Intel Corporation 11.28.1 Overview 11.29 Molecular Health Gmbh 11.29.1 Overview 11.30 Precision For Medicine 11.30.1 Overview List Of Tables Table 1 Leading Companies In The Precision Medicine Market Table 2 Downsizing Cost Of Genome Sequencing Table 3 Factors Impacting The Buyer’s Bargaining Power Table 4 Factors Impacting The Supplier’s Bargaining Power Table 5 Factors Impacting The Threat From Substitute Table 6 Factors Impacting The Threat From New Entrant Table 7 Factors Impacting The Degree Of Competition Table 8 Regulatory Bodies In Precision Medicine Market Table 9 Consortiums In Precision Medicine Market Table 10 Alliances/Associationsin Precision Medicine Market Table 11 Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Billion) Table 12 Pharma & Biotech: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) Table 13 Pharma & Biotech: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Billion) Table 14 Pharma & Biotech: Global Precision Medicine Market Value, By Geography,
2014-2022 ($Billion) Table 15 Key Developments In Pharma & Biotech Companies(2015) Table 16 Diagnostic Tools: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) Table 17 Diagnostic Tools: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Billion) Table 18 Diagnostic Tools: Global Precision Medicine Market Value, By Geography, 20142022 ($Billion) Table 19 Key Developments In Diagnostic Companies(2015) Table 20 Healthcare Its/Big Data: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) Table 21 Healthcare Its/Big Data: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Billion) Table 22 Healthcare Its/Big Data: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Billion) Table 23 Key Developments In Healthcare It/Big Data Companies(2015) Table 24 Clinical Laboratories: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) Table 25 Clinical Laboratories: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Billion) Table 26 Clinical Laboratories: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Billion) Table 27 Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) Table 28 Companion Diagnostics: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) Table 29 Companion Diagnostics: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) Table 30 List Of Approved Companion Diagnostic Devices Table 31 Biomarker: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) Table 32 Biomarker: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) Table 33 List Of Biobanks Table 34 Examples Of Biobanking Initiatives Across Selected Oecd Countries Table 35 Targeted Therapeutics: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) Table 36 Targeted Therapeutics: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) Table 37 Pharmacogenomics: Global Precision Medicine Market Value, By Ecosystem
Players, 2014-2022 ($Million) Table 38 Pharmacogenomics: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) Table 39 Molecular Diagnostics: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) Table 40 Molecular Diagnostics: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) Table 41 Other Sub-Markets: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) Table 42 Other Sub-Markets: Global Precision Medicine Market Value, By Therapeutic Application, 2014-2022 ($Million) Table 43 Global Precision Medicine Market Value, By Therapeutic Applications, 2014-2022 ($Billion) Table 44 Cancer: Global Precision Medicine Market Value, By Ecosystem Players, 20142022 ($Billion) Table 45 Cancer: Global Precision Medicine Market Value, By Sub-Market Types, 20142022 ($Billion) Table 46 Cancer: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Billion) Table 47 Precision Medicine Drugs And Relevant Genes: Oncology Table 48 Precision Medicine Genetic Tests With Respect To Oncology Table 49 Key Developments (2013-2015) Table 50 Cvd: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Billion) Table 51 Cvd: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Billion) Table 52 Cvd: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Million) Table 53 Precision Medicine Drugs And Relevant Genes: Cardiovascular Table 54 Precision Medicine Genetic Tests With Respect To Cardiovascular Table 55 Key Developments (2014-2015) Table 56 Cns: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) Table 57 Cns: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Million) Table 58 Cns: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Million) Table 59 Precision Medicine Drugs And Relevant Genes: Neurology Table 60 Precision Medicine Drugs And Relevantgenes: Psychiatric Disorders
Table 61 Precision Medicine Genetic Tests With Respect To Psychiatric Disorders Table 62 Psychiatric Disorders: Key Developments (2014-2015) Table 63 Infectious Disease: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) Table 64 Infectious Disease: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Million) Table 65 Infectious Disease: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Million) Table 66 Precision Medicine Drugs And Relevant Genes: Infectious Diseases Table 67 Other Therapeutics: Global Precision Medicine Market Value, By Ecosystem Players, 2014-2022 ($Million) Table 68 Other Therapeutics: Global Precision Medicine Market Value, By Sub-Market Types, 2014-2022 ($Million) Table 69 Other Therapeutics: Global Precision Medicine Market Value, By Geography, 2014-2022 ($Million) Table 70 Precision Medicine Drugs And Relevant Genes: Other Diseases Table 71 Precision Medicine Genetic Tests With Respect To Other Diseases Table 72 Global Precision Medicine Market Value, By Geography, 2014-2022 ($Billion) Table 73 Americas: Global Precision Medicine Market Value, By Ecosystem Players, 20142022 ($Billion) Table 74 Americas: Global Precision Medicine Market Value, By Ecosystem Players, 20142022 ($Billion) Table 75 Americas: Global Precision Medicine Market Value, By Therapeutic Applications, 2014-2022 ($Billion) Table 76 Europe: Global Precision Medicine Market Value, By Ecosystem Players, 20142022 ($Billion) Table 77 Europe: Global Precision Medicine Market Value, By Therapeutic Applications, 2014-2022 ($Billion) Table 78 Apac: Global Precision Medicine Market Value, By Ecosystem Players, 20142022 ($Billion) Table 79 Apac: Global Precision Medicine Market Value, By Therapeutic Applications, 2014-2022 ($Million) Table 80 Row: Global Precision Medicine Market Value, By Ecosystem Players, 20142022 ($Million) Table 81 Row: Global Precision Medicine Market Value, By Therapeutic Applications, 2014-2022 ($Million) List Of Figures Figure 1 Precision Medicine Market Study Figure 2 Research Methodology Figure 3 Different Phases Of Research Methodology For The Global Market
Figure 4 Precision Medicine Market: Research Methodology Figure 5 Global Precision Medicine Market Share, By Ecosystem, 2014-2022 ($Billion) Figure 6 Global Precision Medicine Market Size, By Sub-Market Type, 2014 – 2022 (Billion) Figure 7 Global Precision Medicine Market Size, By Therpeutic Application, 2014 – 2022 (Billion) Figure 8 Global Precision Medicine Market Size, By Geography, 2014 – 2022 ($Billion) Figure 9 Timeline Of Precision Medicine Figure 10 Precision Medicine: Benefits Figure 11 Examples: Applied Areas Of Precision Medicine Figure 12 Elements Of Precision Medicine Technology Figure 13 Different Type Of Data Used By Big Data Companies Figure 14 Precision Medicine : Areas Of Interest Figure 15 Precision Medicine: Partnerships, Agreements, And Collaborations (2015) Figure 16 Precision Medicine : Mergers & Acquisitions( 2015) Figure 17 Precision Medicine: Key Product Launch & Developments (2015) Figure 18 Precision Medicine: Key Business Expansions & Contracts (2015) Figure 19 Precision Medicine : Key Patents/ Approvals ( 2015) Figure 20 Precision Medicine: Events & Recognition (2015) Figure 21 Market Drivers And Challenges Figure 22 Benefits Of Precision Medicine To Patients Figure 23 Major Barriers Caused By Regulation And Standards Figure 24 Flow Chart Of Precision Medicine Figure 25 Precision Medicine Market: Porter Five Force Analysis Figure 26 Roles And Responsibilities Of Healthcare Policy Makers Figure 27 Role Of Fda In Precision Medicine Figure 28 Classification Of Medical Devices Figure 29 Global Precision Medicine Market By Ecosystem Players Figure 30 Role Of Pharmaceuticals And Biotech Companies Figure 31 Challenges Faced By Pharma & Biotech Companies Figure 32 Diagnostic Tests Benefits For Stakeholders Figure 33 Challenges Faced By Diagnostic Companies Figure 34 Benefits Of Big Data
Figure 35 Transformation Of Medicine Figure 36 Basic Ingredients Provided By Big Data For Precision Medicine Figure 37 Challenges Faced By Big Data Companies Figure 38 Oecd Recommendations On The Governance Of Clinical Trials Figure 39 Types Of Precision Medicine Sub-Market Figure 40 Benefits Of Companion Diagnostics Figure 41 Function Of Biomarkers Figure 42 Biobanks Services Figure 43 Development In Pgx Figure 44 Model Systems Used In Pgx Figure 45 Challenges Of Pgx Studies Figure 46 Figure Title Missing Figure 47 Molecular Diagnostics: Application Figure 48 Molecular Diagnostics: Benefits Figure 49 Global Precision Medicine Market: By Therapeutics Figure 50 Target Scope Of Precision Medicine By Cancer Types Figure 51 Global Precision Medicine Market Classification, By Geography Figure 52 Key Drivers For Precision Medicine: North America Figure 53 Objectives Of The Precision Medicine Initiative Figure 54 Apac: Market Challenges Figure 55 Abbott: Overall Financials ($Billion), 2012-2014 Figure 56 Abbott: Net Revenue By Segments ($Billion), 2012-2014 Figure 57 Abbott: Net Revenue By Region, 2012-2014 ($Billion) Figure 58 Abbott: Swot Analysis Figure 59 Almac: Swot Analysis Figure 60 Asuragen: Swot Analysis Figure 61 Biomerieux: Overall Financials ($Million), 2012-2014 Figure 62 Biomerieux: Net Revenue By Region, 2014 Figure 63 Biomerieux: Net Revenue By Segment, 2014 Figure 64 Biomerieux: Swot Analysis Figure 65 Cepheid: Overall Financials, 2012-2014 ($Million)
Figure 66 Cepheid: Net Revenue, By Segments, 2012-2014 ($Million) Figure 67 Cepheid: Net Revenue, By Region, 2012-2014 ($Million) Figure 68 Cepheid: Swot Analysis Figure 69 Cetics Healthcare: Swot Analysis Figure 70 Ge Corporation: Overall Financials, 2012-2014 ($Billion) Figure 71 Ge Corporation: Net Revenue, By Segments, 2012-2014 ($Million) Figure 72 Ge Corporation: Healthcare Segment, 2014 Figure 73 Gsk: Overall Financials, 2012-2014 ($Billion) Figure 74 Gsk: Net Revenue By Segment, 2014 ($Billion) Figure 75 Gsk: Net Revenue By Region, 2014 ($Billion) Figure 76 Gsk: Net Revenue By Therapeutics, 2014 ($Billion) Figure 77 Intomics: Swot Analysis Figure 78 J&J: Overall Financials, 2012 - 2014 ($Billion) Figure 79 J&J: Net Revenue By Segment, 2012 - 2014 ($Million) Figure 80 J&J: Net Revenue By Region, 2012 - 2014 ($Million) Figure 81 Labcorp: Overall Financials ($Million), 2012-2014 Figure 82 Net Revenue By Segments, 2012-2014 ($Million) Figure 83 Labcorp: Swot Analysis Figure 84 Medtronic: Overall Financials, 2012 - 2014 ($Million) Figure 85 Novartis: Overall Financials, 2012 - 2014 ($Billion) Figure 86 Novartis: Net Revenue By Region, 2014 ($Billion) Figure 87 Novartis: Net Revenue By Segment, 2014 ($Billion) Figure 88 Pfizer: Overall Financials, 2012 – 2014 ($Billion) Figure 89 Pfizer: Net Revenue, By Segment, 2012-2014 ($Million) Figure 90 Pfizer: Net Revenue, By Region, 2012-2014 ($Billion) Figure 91 Pfizer: Swot Analysis Figure 92 Qiagen: Overall Financials ($Million), 2012-2014 Figure 93 Qiagen: Net Revenue By Region ($Million), 2014 Figure 94 Qiagen: Net Revenue By Segment, 2014 Figure 95 Quest: Overall Financials, 2012 - 2014 ($Million) Figure 96 Quest: Net Revenue, By Segment, 2012 - 2014 ($Million) Figure 97 Quest: Swot Analysis
Figure 98 Randox: Swot Analysis Figure 99 Roche: Overall Financials, 2012-2014 ($Billion) Figure 100 Roche: Net Revenue, By Segments, 2012-2014 ($Billion) Figure 101 Roche: Swot Analysis Figure 102 Sanofi Pharma: Overall Financials, 2012-2014($Billion) Figure 103 Sanofi Pharma: Net Revenue, By Segments, 2012-2014 ($Bilion) Figure 104 Takeda: Overall Financials, 2012-2014 ($Billion) Figure 105 Takeda: Swot Analysis Figure 106 Teva: Overall Financials, 2012 – 2014 ($Billion) Figure 107 Teva: Net Revenue Share, By Segment (2014) Figure 108 Teva: Net Revenue Share, By Region (2014) Figure 109 Teva: Swot Analysis
marketresearchfuture.com / Phone (US) + 1-646-845-9349 (UK) +44 208 133 9349